Stay updated on Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.4 to v3.6.5. This is a minor maintenance update and does not change the study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-11T21:53:15.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page revision number was updated from v3.6.3 to v3.6.4, indicating a small update to the page framework rather than the study content.
    Difference
    0.0%
    Check dated 2026-07-28T14:59:22.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    The Publications section now includes a complete bibliographic entry for the SKYSCRAPER-06 publication (Socinski et al.), JAMA Oncol. 2026;12(6):619-627, DOI 10.1001/jamaoncol.2026.0818. The earlier Online ahead of print entry (April 30, 2026; e260818) has been removed.
    Difference
    0.0%
    Check dated 2026-06-30T01:52:47.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    New sections to guide users have been added ('No longer looking for participants', 'How to Read a Study Record', 'Common Questions', 'How to Join a Study') and a new revision label v3.6.0 appears. The heading 'Intervention / Treatment' was replaced by 'Intervention/Treatment', and the prior revision label v3.5.5 was removed.
    Difference
    0.2%
    Check dated 2026-06-15T20:51:09.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Results have been posted for the study, and the page now notes 127 locations. The update also introduces detailed outcome definitions for progression-free survival (PFS) and overall survival (OS), along with associated measurement timelines and related data elements.
    Difference
    2%
    Check dated 2026-06-08T17:38:57.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The study's publication citation for the Phase 3 SKYSCRAPER-06 trial was updated to include the online identifier e260818 and the DOI, replacing the previous entry that did not include the identifier.
    Difference
    0.0%
    Check dated 2026-06-01T14:40:05.000Z thumbnail image

Stay in the know with updates to Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo vs. Pembrolizumab in Lung Cancer Clinical Trial page.